Stem Cell Network
For More Information
For more information, please go to the sponsor website.
In March 2016 the Government of Canada provided an additional $12 million over two years to SCN to continue to support excellence and global leadership in translational stem cell research. The three key funding programs are:
Impact Research Agreements: Eligible projects will fall under one of three categories: clinical translation, commercialization or public policy. These projects are best suited to research that is ready to move down a translational path, or will support the development of evidence-based policies and practices.
Disease Team Research Agreements: Eligible projects will bring together multiple investigators with different expertise who will collaborate on initiatives that are developing novel cellular or stem cell-related therapeutic approaches to tissue repair and regeneration for specific diseases. Examples of such diseases include, but are not restricted to, diabetes, heart disease, septic shock and lung disease.
Clinical Trial Research Agreements: Eligible projects will be phase 1 or 2 clinical trials and have received Health Canada approval. It is expected that successful projects will show incremental benefit to the patient, as well as provide an economic analysis of the potential cost of treatment compared to current best-available standard of care.
Faculty must be eligible to receive grant funding from CIHR, SSHRC or NSERC
**See specific program sponsor guidelines for other eligibility requirements**
Impact Research Agreements: $100,000 for 1 yr (Clinical translation), $100,000 for 1 yr (Commercialization) and $50,000 for 1 yr (Public policy)
Disease Team Research Agreements: $500,000 over 2 fiscal years
Clinical Trial Research Agreements: $1M over 2 fiscal years
In order to receive the award, successful applicants must execute a Standard SCN Agreement (through which they will become a member of the Stem Cell Network), and take on all of the associated rights and obligations. These obligations include the requirement to provide SCN office with project updates and reports as requested.
Letter of Intent Deadline
?To sponsor directly: June 15, 2016 midnight EDT for Disease Team and Clinical Trial Research Agreements ONLY
To Office of Research: June 8, 2016 for Impact Research Agreement Program ONLY
Please submit your application/proposal along with an OR5 form to firstname.lastname@example.org
To sponsor directly: June 15, 2016 midnight EDT for Impact Research Agreement Program ONLY
How to Apply
Applicant to email completed LOI or proposal by e-mail to email@example.com